Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACENasim Mavaddat, Debra Frost, Radka Platte et al.|JNCI Journal of the National Cancer Institute|2013Cited by 946
Rapid reviews methods series: guidance on rapid qualitative evidence synthesisAndrew Booth, Fiona Campbell, Isolde Sommer et al.|BMJ Evidence-Based Medicine|2024Cited by 25
Lymphocyte Telomere Length Is Long in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Regardless of Cancer-Affected StatusKaren A. Pooley, Alison M. Dunning, Lesley McGuffog et al.|Cancer Epidemiology Biomarkers & Prevention|2014Cited by 23